The fourth annual Oxford Technology Showcase was held on Wednesday 6th July at Oxford’s Saïd Business School. The event brought together experts and innovators from Oxford University, the Oxford University Hospital Trust and the Oxfordshire region. Over 300 investors, entrepreneurs, healthcare companies, researchers and clinicians attended.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
In conjunction with Shakespeare’s Dead at the Bodleian’s Weston Library: TalkAbout Guides App available 1 July – 18 September 2016, free download for iOs and Android.
Genomics plc and DNAnexus collaborate to develop solutions for population-scale sequencing analysis
Celleron Therapeutics is developing personalised medicine for cancer patients. The company has announced results from its first human trial in patients at Oxford’s Churchill Hospital with advanced treatment-resistant aggressive cancer.
Nasdaq-listed Oxford spinout Summit Therapeutics has hit its first research milestone as part of a multiyear strategic alliance with the University of Oxford. The collaboration is focussed on developing future-generation utrophin modulators for the potential treatment of all patients with the progressive muscle wasting disorder Duchenne Muscular Dystrophy.
Perspectum announced today it has been given US FDA clearance to market its test for diagnosing and measuring liver disease.